459 related articles for article (PubMed ID: 27175676)
21. Increased intramyocellular lipid accumulation in HIV-infected women with fat redistribution.
Torriani M; Thomas BJ; Barlow RB; Librizzi J; Dolan S; Grinspoon S
J Appl Physiol (1985); 2006 Feb; 100(2):609-14. PubMed ID: 16223978
[TBL] [Abstract][Full Text] [Related]
22. Brief Report: Circulating Markers of Immunologic Activity Reflect Adiposity in Persons With HIV on Antiretroviral Therapy.
Koethe JR; Jenkins CA; Furch BD; Lake JE; Barnett L; Hager CC; Smith R; Hulgan T; Shepherd BE; Kalams SA
J Acquir Immune Defic Syndr; 2018 Sep; 79(1):135-140. PubMed ID: 29794823
[TBL] [Abstract][Full Text] [Related]
23. Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.
Brown TT; Li X; Cole SR; Kingsley LA; Palella FJ; Riddler SA; Chmiel JS; Visscher BR; Margolick JB; Dobs AS
AIDS; 2005 Sep; 19(13):1375-83. PubMed ID: 16103768
[TBL] [Abstract][Full Text] [Related]
24. [Evaluation of leptin levels in plasma and their reliance on other hormonal factors affecting tissue fat levels in people with various levels of endogenous cotisol].
Robaczyk MG
Ann Acad Med Stetin; 2002; 48():283-300. PubMed ID: 14601484
[TBL] [Abstract][Full Text] [Related]
25. Reversion of metabolic abnormalities after switching from HIV-1 protease inhibitors to nevirapine.
Martínez E; Conget I; Lozano L; Casamitjana R; Gatell JM
AIDS; 1999 May; 13(7):805-10. PubMed ID: 10357379
[TBL] [Abstract][Full Text] [Related]
26. Effect of nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy on dysglycemia and insulin sensitivity in South African HIV-infected patients.
Dave JA; Lambert EV; Badri M; West S; Maartens G; Levitt NS
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):284-9. PubMed ID: 21602696
[TBL] [Abstract][Full Text] [Related]
27. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance.
Rao MN; Mulligan K; Tai V; Wen MJ; Dyachenko A; Weinberg M; Li X; Lang T; Grunfeld C; Schwarz JM; Schambelan M
J Clin Endocrinol Metab; 2010 Sep; 95(9):4361-6. PubMed ID: 20610601
[TBL] [Abstract][Full Text] [Related]
28. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
29. Abdominal adiposity assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin sensitivity in older adults.
Lee CC; Glickman SG; Dengel DR; Brown MD; Supiano MA
J Gerontol A Biol Sci Med Sci; 2005 Jul; 60(7):872-7. PubMed ID: 16079210
[TBL] [Abstract][Full Text] [Related]
30. Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.
Brown TT; Ruppe MD; Kassner R; Kumar P; Kehoe T; Dobs AS; Timpone J
J Clin Endocrinol Metab; 2004 Mar; 89(3):1200-6. PubMed ID: 15001610
[TBL] [Abstract][Full Text] [Related]
31. Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
Duvivier C; Ghosn J; Assoumou L; Soulié C; Peytavin G; Calvez V; Génin MA; Molina JM; Bouchaud O; Katlama C; Costagliola D;
J Antimicrob Chemother; 2008 Oct; 62(4):797-808. PubMed ID: 18641035
[TBL] [Abstract][Full Text] [Related]
32. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
[TBL] [Abstract][Full Text] [Related]
33. Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects.
Haufe S; Witt H; Engeli S; Kaminski J; Utz W; Fuhrmann JC; Rein D; Schulz-Menger J; Luft FC; Boschmann M; Jordan J
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):637-642. PubMed ID: 27134061
[TBL] [Abstract][Full Text] [Related]
34. Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.
Ho JE; Larson MG; Ghorbani A; Cheng S; Chen MH; Keyes M; Rhee EP; Clish CB; Vasan RS; Gerszten RE; Wang TJ
PLoS One; 2016; 11(2):e0148361. PubMed ID: 26863521
[TBL] [Abstract][Full Text] [Related]
35. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
36. Rising Obesity Prevalence and Weight Gain Among Adults Starting Antiretroviral Therapy in the United States and Canada.
Koethe JR; Jenkins CA; Lau B; Shepherd BE; Justice AC; Tate JP; Buchacz K; Napravnik S; Mayor AM; Horberg MA; Blashill AJ; Willig A; Wester CW; Silverberg MJ; Gill J; Thorne JE; Klein M; Eron JJ; Kitahata MM; Sterling TR; Moore RD;
AIDS Res Hum Retroviruses; 2016 Jan; 32(1):50-8. PubMed ID: 26352511
[TBL] [Abstract][Full Text] [Related]
37. Circulating branched-chain amino acid concentrations are associated with obesity and future insulin resistance in children and adolescents.
McCormack SE; Shaham O; McCarthy MA; Deik AA; Wang TJ; Gerszten RE; Clish CB; Mootha VK; Grinspoon SK; Fleischman A
Pediatr Obes; 2013 Feb; 8(1):52-61. PubMed ID: 22961720
[TBL] [Abstract][Full Text] [Related]
38. HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy.
Bares SH; Smeaton LM; Xu A; Godfrey C; McComsey GA
J Womens Health (Larchmt); 2018 Sep; 27(9):1162-1169. PubMed ID: 29608129
[TBL] [Abstract][Full Text] [Related]
39. Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study.
Boyd MA; Amin J; Mallon PW; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA;
Lancet HIV; 2017 Jan; 4(1):e13-e20. PubMed ID: 27815068
[TBL] [Abstract][Full Text] [Related]
40. Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults.
Redhage LA; Shintani A; Haas DW; Emeagwali N; Markovic M; Oboho I; Mwenya C; Erdem H; Acosta EP; Morrow JD; Hulgan T
HIV Clin Trials; 2009; 10(3):181-92. PubMed ID: 19632957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
